New Insights into Oligo-Recurrence of Various Cancers (2nd Edition)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 76
Special Issue Editor
Interests: breast surgical oncology; tumor biology; clinical trial; translational research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is the second edition of a previous Special Issue “New Insights into Oligo-Recurrence of Various Cancers”.
The most dramatic development in oncology areas in recent decades has been the demonstration of the value of adding local therapy to systemic therapy for oligo-recurrence (with local therapy alone being rarely assigned).
According to Niibe et al. (2006), oligo-recurrence is defined as having a controlled primary tumor with no more than five regional lymph nodes and/or distant metastasis/recurrence sites (including brain, viscera, bone, etc.). Furthermore, local treatment is performed on all active lesions.
While maintaining this general framework, the indications are subdivided individually for NSCLC, breast cancer, prostate cancer, etc., along with the oligo-recurrence treatment method.
This is becoming a specific treatment guideline and is very important. Underpinning this foundation are less invasive local therapies, rapidly increasing precision in diagnostic imaging, and cancer-specific advances in systemic therapy.
The theme of this Special Issue of Cancers is “New Insights into Oligo-Recurrence of Various Cancers”. We are soliciting original and review papers for more precise definitions, treatment methods, diagnostic methods, etc., of oligo-recurrence that are more subdivided for each carcinoma. Through this Special Issue, we hope that oligo-recurrence will be widely applied and that great progress will be achieved toward the next era.
Dr. Tadahiko Shien
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oligo-recurrence
- diagnostic imaging
- systemic therapy
- local therapy
- controlled primary tumor
- regional lymph nodes
- distant metastasis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- New Insights into Oligo-Recurrence of Various Cancers in Cancers (6 articles)
